Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
36.85M
Cash
9.601M
Avg Qtr Burn
-3.926M
Short % of Float
2.94%
Insider Ownership
23.35%
Institutional Own.
4.68%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
THIO Details Non-small cell lung carcinoma, Cancer | Phase 3 Initiation | |
THIO Details Non-small cell lung carcinoma, Cancer, Hepatocellular carcinoma, Small cell lung cancer, Colorectal cancer | Phase 2 Update |